Lacosamide 71921-0221
Product NDC
71921-0221- Manufacturer
- Florida Pharmaceutical Products, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- September 21, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA208308
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 100 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(1)
60 TABLET in 1 BOTTLE (71921-221-06)